Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01981109 · ClinicalTrials.gov registry record
Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer
A clinical trial, sponsored by Dendreon.
- Terminated
- Registry status
- 225
- Enrollment target
NCT01981109 is a clinical trial that was terminated before completion, run by Dendreon. The registered enrollment target is 225 participants.
The verdict
NCT01981109 was terminated before completion, sponsored by Dendreon.
- TERMINATED
- Registry status
- 225 participants
- Enrollment target
Study Summary
The primary purpose of this research is to describe patient characteristics predictive of an imaging study positive for distant metastases in patients with castration-resistant prostate cancer and no known distant metastases.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2012-01 |
| Est. Completion | 2017-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01981109
The ClinicalTrials.gov registry entry for NCT01981109 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dendreon, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01981109 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01981109 about?
NCT01981109 is a clinical study titled "Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer". The primary purpose of this research is to describe patient characteristics predictive of an imaging study positive for distant metastases in patients with castration-resistant prostate cancer and no known distant metastases.
What is the current status of trial NCT01981109?
This trial is currently terminated. The enrollment target is 225 participants. The study started on 2012-01. Estimated completion is 2017-07.
Who is sponsoring clinical trial NCT01981109?
This trial is sponsored by Dendreon, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.